Despite this, functional differences between different doses of anti-CD25 Ab were observed in the resulting growth curves, suggesting CD4+CD25+ Treg cells are involved in the T cell response that confers the tumour growth advantage following feeding. This evidence concerns the gene CD4 and neoplasm.